Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$178.9K
15.67K shares
What this filing means
KAISER PETER plans to sell 15.67K shares of OCULAR THERAPEUTIX, INC valued at approximately $178.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/24/2025ACC: 0001950047-25-009286
Officer· Chief Development Officer
Since Feb 2026
15.67K
Shares to sell
$178.9K
Approx. market value
3.01K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
11/22/2025
3.01KTotal acquired3.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/22/2025 | Restricted stock vesting under a registered plan Not Applicable | 3.01K | — |
| Total | 3.01K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
9.65K
Market value
$106.5K
10/2/2025
—Completed
Units to sell
3.01K
Market value
$36.3K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.01K
Market value
$36.2K
11/24/2025
Total
Units
15.67K
Value
$178.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/2/2025 | 9.65K | $106.5K | — | Completed |
8/25/2025 | 3.01K | $36.3K | — | Completed |
| Planned — Approximate Date | ||||
11/24/2025 | 3.01K | $36.2K | NASDAQ | Planned |
| Total | 15.67K | $178.9K | ||